Jiangsu Huaiyu Pharmaceutical

Jiangsu Huaiyu Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. Headquartered in Huai'an, Jiangsu Province, the company operates modern, GMP-compliant manufacturing facilities dedicated to high-quality chemical synthesis. Its core product portfolio focuses on small molecule therapeutics for chronic conditions, particularly in the fields of endocrinology and cardiovascular health. Key products include widely used treatments such as metformin and gliclazide for the management of type 2 diabetes. In addition to its manufacturing capabilities, the company maintains a robust logistics and distribution network serving both domestic Chinese and international markets. Huaiyu Pharmaceutical is recognized for its commitment to quality control and its role as a reliable supplier in the global pharmaceutical supply chain.